Clinical Trials

Anemia, Myeloproliferative Disorders, Primary Myelofibrosis

NCT03976882 2025-05-16

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Subjects With Malignancy.

129 enrolled

Phase 3 Active not recruiting

Chemotherapy-Induced Thrombocytopenia

NCT05864014 2025-04-16

Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.

213 enrolled

Chemotherapy-Induced Thrombocytopenia

NCT01130025 2025-02-24

Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in Cancer

900 enrolled

Venous Thromboembolism

NCT03471078 2023-09-28

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

122 enrolled 19 charts

Thrombocytopenia

NCT05261646 2023-09-28

A Clinical Study of Hetrombopag Olamine Tablets in Adults Receiving 21-day Cycles of Chemotherapy for Solid Tumours, Who Are Delayed for at Least 1 Week From Their Scheduled Cycle Because of Chemotherapy-induced Thrombocytopenia

Phase 3 Withdrawn

Chemotherapy-Induced Thrombocytopenia

NCT01583218 2023-08-07

APEX

7,513 enrolled 18 charts 2 FDA

Venous Thromboembolism

NCT03036813 2023-07-27

GBT_HOPE

449 enrolled 17 charts 2 FDA

Anemia, Sickle Cell

NCT05301517 2023-06-06

A Study to Evaluate the Efficacy and Safety of Roxadustat for the Treatment of Anemia in Participants Receiving Chemotherapy Treatment for Non-Myeloid Malignancies

159 enrolled

Chemotherapy Induced Anemia

NCT05704894 2023-01-30

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Phase 3 Unknown

320 enrolled

Anemia, Neoplasms

NCT03020160 2023-01-11

HAVEN 4

48 enrolled 44 charts 2 FDA

Hemophilia A

NCT00858364 2022-11-30

Anemia Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Chemotherapy

Classical hematologyThoracic

2,549 enrolled 19 charts

Anemia, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasms, Pleural Effusion, Pleural Effusion, Malignant

NCT02847637 2022-11-16

HAVEN 3

152 enrolled 46 charts 2 FDA

Hemophilia A

NCT02467868 2022-02-14

Efficacy and Safety Study With MYL-1401H and Neulasta

BreastClassical hematology

193 enrolled

Breast Neoplasms, Neutropenia, Chemotherapy-Induced Febrile Neutropenia

NCT04466137 2022-02-09

Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy

398 enrolled

Neutropenia, Febrile Neutropenia

NCT02631070 2021-12-17

MEDALIST

229 enrolled 36 charts 3 FDA

Anemia, Myelodysplastic Syndromes

NCT02055781 2021-11-18

PAC326

311 enrolled 12 charts

Anemia, Bone Marrow Diseases, Hematologic Diseases, Hemorrhagic Disorders, Myeloproliferative Disorders, Polycythemia Vera, Splenomegaly, Thrombocythemia, Essential, Thrombocytopenia, Primary Myelofibrosis

NCT02622321 2021-06-24

HAVEN 1

113 enrolled 45 charts 2 FDA

Hemophilia A

NCT02795767 2021-06-02

HAVEN 2

88 enrolled 65 charts 2 FDA

Hemophilia A

NCT01773187 2020-09-29

Pacritinib Versus Best Available Therapy to Treat Myelofibrosis

327 enrolled 11 charts

Anemia, Bone Marrow Diseases, Hematologic Diseases, Myeloproliferative Disorders, Polycythemia Vera, Splenomegaly, Thrombocythemia, Essential, Thrombocytopenia, Primary Myelofibrosis

NCT01663441 2020-09-16

A Phase Ⅲa Study of Genetically Modified Recombinant Human Interleukin-11

62 enrolled

Thrombocytopenia

NCT01179217 2020-08-19

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

230 enrolled 19 charts 2 FDA

Vaso-Occlusive Crises, Anemia, Sickle Cell

NCT01241500 2020-06-30

ONTIME

Classical hematologyMyeloidOther hematologic neoplasm

299 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT01928537 2020-06-30

Efficacy and Safety of IV Rigosertib in MDS Patients With Excess Blasts Progressing After Azacitidine or Decitabine

Classical hematologyMyeloidOther hematologic neoplasm

67 enrolled

Cytopenia, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT02555878 2019-09-12

A Study to Evaluate the Efficacy and Safety of Rivaroxaban Venous Thromboembolism (VTE) Prophylaxis in Ambulatory Cancer Participants

841 enrolled 24 charts

Neoplasms, Venous Thromboembolism

NCT01295710 2019-04-09

Study of US-ATG-F to Prevent Chronic Graft Versus Host Disease (GVHD)

Classical hematologyLymphoidMyeloidOther hematologic neoplasm

260 enrolled 26 charts

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02073682 2019-03-06

Cancer Venous Thromboembolism (VTE)

1,046 enrolled 24 charts

Neoplasms, Pulmonary Embolism, Venous Thrombosis, Venous Thromboembolism

NCT03776032 2018-12-20

A Novel Erythropoiesis Stimulating Protein (NESP; Darbopoetin Alfa) for the Treatment of Anemia in Lung Cancer Patients Receiving Multi-cycle Platinum-Containing Chemotherapy

Classical hematologyThoracic

320 enrolled

Anemia, Lung Neoplasms

NCT02389621 2018-10-30

L-PLUS 2

215 enrolled 24 charts 2 FDA

Thrombocytopenia

NCT00338286 2018-03-19

A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy

BreastClassical hematology

2,098 enrolled 12 charts

Anemia, Breast Neoplasms, Neoplasm Metastasis

NCT00236951 2018-02-20

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

224 enrolled 9 charts

Anemia, Neoplasms

NCT00911170 2017-12-29

PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study

Classical hematologyGastrointestinal

847 enrolled 21 charts

Colonic Neoplasms, Fever, Neoplasms, Neutropenia, Rectal Neoplasms, Colorectal Neoplasms, Febrile Neutropenia

NCT00711958 2017-09-05

Study to Assess the Efficacy and Safety of HX575 in the Treatment of Chemotherapy Associated Anemia in Cancer Patients

114 enrolled 10 charts

Anemia

NCT02767765 2017-04-04

A Study of Recombinant Human Erythropoietin Beta (NeoRecormon) in Anemic Cancer Participants Treated With Chemotherapy

61 enrolled 11 charts

Anemia

NCT01444417 2017-02-09

Safety and Efficacy Study of Romiplostim to Treat Immune Thrombocytopenia (ITP) in Pediatric Patients

62 enrolled 16 charts 2 FDA

Purpura, Thrombocytopenic, Thrombocytopenia, Purpura, Thrombocytopenic, Idiopathic

NCT02104830 2016-10-24

Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Breast Cancer Patients

BreastClassical hematology

135 enrolled 18 charts

Breast Neoplasms, Neutropenia, Febrile Neutropenia

NCT00109538 2015-05-01

Study of Lonafarnib Versus Placebo in Subjects With Either Myelodysplastic Syndrome (MDS) or Chronic Myelomonocytic Leukemia (CMML) (Study P02978AM3)(TERMINATED)

Classical hematologyMyeloidOther hematologic neoplasm

47 enrolled

Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic

NCT00702702 2014-08-21

Safety and Efficacy of Proellex in Pre-menopausal Anemic Women With Symptomatic Uterine Fibroids

56 enrolled 1 chart

Anemia, Leiomyoma

NCT00785356 2014-08-21

Safety and Efficacy of Proellex in Pre-Menopausal Anemic Women With Symptomatic Uterine Fibroids

8 enrolled 1 chart

Anemia, Leiomyoma

NCT01101399 2013-12-18

FID-CHEMO

Classical hematologyLymphoid

19 enrolled

Anemia, Lymphoproliferative Disorders, Anemia, Iron-Deficiency

NCT00148421 2013-05-15

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

Anemia

NCT00091858 2013-05-08

Study of Darbepoetin Alfa for the Treatment of Anemia of Cancer

1,000 enrolled